Itamar Medical Inc competitors

Experienced Chief Executive Officer with a demonstrated history of working in the medical device industry. Skilled in Healthcare Consulting, Negotiation, Business Planning, Sales, and Customer Relationship Management (CRM). Strong business development professional with a Bachelor of Science (BS) focused in Social Sciences from Florida State University.

John T. Spitznagel is a Chief Executive Officer at NovaSom Inc and is based in Auburn, New York.

Mary Fisher brings more than 25 years of experience in the pharmaceutical and biotechnology industries. Ms. Fisher currently serves as Chief Executive Officer and Director at Colorescience, a former division of SkinMedica, Inc., where she served as Chief Executive Officer from 2008 until 2012, when she led the successful sale of the company to Allergan, Inc. for $375 million. Prior to joining SkinMedica, Ms. Fisher was the Chief Operating Officer of Acorda Therapeutics, a biotechnology company focused on developing products for the treatment of central nervous system disorders. There, she helped execute the company’s restructuring, initial public offering and a $50 million acquisition that transitioned Acorda from a developmental platform to a commercial stage operation. Ms. Fisher has served as a Pharmaceutical Consultant for companies such as Acorda Therapeutics and Roche Diagnostics and specialized in commercialization strategy, resource and outsource planning, pricing strategy and tactics, distribution planning, managed care contracting and forecasting. Previously, she held the role of Vice President, Strategic Healthcare and Commercial Operations at Cephalon, Inc., and Manager, Communications at Immunex. She currently serves as a Board Member of Zeltiq, a Board Member of OvaScience, as well as the Neuroscience Nursing Foundation and is a Member of the Women’s Dermatological Society and the Dermatology Foundation Leader’s Society.

Ronald Terry Burr (born September 30, 1964) is an American Internet and media entrepreneur, based in Los Angeles, CA. He is the holder of nine internet patents and the co-founder and original chief executive officer of NetZero. During his career he has created over $1 Billion in value for shareholders. Early in his career Burr developed software applications which are used by IBM, Verizon Wireless, and Sempra Energy. Burr is often a guest speaker at industry conferences and was named by InfoWorld as one of the Top 50 IT executives at xSP’s, by Interactive Week as one of the 25 Top Unsung Hero's of the Net and was a finalist for Ernst & Young's Entrepreneur of the Year award. Burr was also the Chief Executive Officer of online advertising company WebVisible, Inc. until its closure in 2011 due to unpaid debts.

Dave Parks has over 25 years of experience in the digital strategy and transformative solutions arena. Beginning his career as a software developer, he eventually transitioned into technology management, technical sales and solution sales roles. Dave founded Adjacent Technologies, Inc. in 2002, and was acting CEO until merging Adjacent with enChoice in late 2019. Dave holds a bachelor’s degree in Business from Texas A&M University.

Larry Miller is an Instructor:Medicine at Harvard Medical School, Venture Partner at Sanderling Ventures, and Founding Partner at Mediphase Venture Partners and is based in Boston, Massachusetts. He has worked as Vice President at Hawaii Public Radio; Board Member at TETRAPHASE PHARMACEUTICALS INC; and Founder, General Partner at Mediphase. Lawrence studied at Harvard University until 1973, Harvard Medical School until 1978, and Massachusetts General Hospital and Harvard Medical School between 1978 and 1982.